期刊
NEUROLOGIC CLINICS
卷 23, 期 1, 页码 77-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ncl.2004.09.002
关键词
-
Multiple sclerosis (MS) is a chronic neurologic disease affecting approximately I million adults worldwide. Relapses and progression are the two basic clinical phenomena of prototypic MS. Relapses are the clinical expression of acute focal or multifocal inflammatory demyelination disseminated in the central nervous system, whereas progression reflects the occurrence of chronic demyelination, axonal loss, and gliosis. Early in the disease, remission of symptoms likely is the result of remyelination and resolution of inflammation, but after recurrent attacks, remyelination is limited. Inflammatory and noninflammatory factors likely contribute to short- and long-term disability in MS. This review highlights recent advances in experimental neuropathology that have contributed to a better understanding of MS lesion pathogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据